Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 1Castration-resistant Prostate Cancer 1Castration Resistant Metastatic Prostate Cancer 1

Interventions

Specimen Handling 313Magnetic Resonance Spectroscopy 272pembrolizumab 263Carboplatin 190Cyclophosphamide 177Biopsy 177Cisplatin 165Paclitaxel 137Gemcitabine 137Bevacizumab 122fludarabine 115Nivolumab 114Radiotherapy 111venetoclax 98Oxaliplatin 97Fluorouracil 87Docetaxel 85Dexamethasone 83Capecitabine 83Pemetrexed 76Drug Therapy 76Rituximab 75Leucovorin 71durvalumab 70Radiosurgery 67Doxorubicin 64Blood Specimen Collection 64Standard of Care 63Injections 62atezolizumab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × testosterone enanthate × 90 days × Clear all
NCT06594926 2026-04-24

WOMBAT

Australian and New Zealand Urogenital and Prostate Cancer Trials Group

Phase 2 Recruiting
69 enrolled
Genitourinary

Prostatic Neoplasms

NCT03522064 2026-04-23

HiTeCH

St Vincent's Hospital, Sydney

Phase 2 Recruiting
30 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04363164 2026-04-06

Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Recruiting
150 enrolled
Genitourinary

Castration Resistant Metastatic Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡